trending Market Intelligence /marketintelligence/en/news-insights/trending/HywFcR2Nnh-X2TXds7l9fQ2 content esgSubNav
In This List

Can-Fite BioPharma to raise $5M in registered direct offering

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Can-Fite BioPharma to raise $5M in registered direct offering

Can-Fite BioPharma Ltd. is looking to raise $5 million in a registered direct offering of American depositary shares.

The company plans to issue 2.5 million ADS at $2 apiece, complete with warrants to purchase another 1.25 million ADS at $2.25 apiece.

The warrants are exercisable after six months from the date of issue and expire within a 5.5- year period.

The offering closes Jan. 24, with Rodman & Renshaw acting as the exclusive placement agent for the offering.